October 2, 2019
As data personalizes medtech, how will you serve tomorrow’s consumer?
The global medtech industry’s revenues and valuations continue to rise. But to remain relevant, companies must begin to create the products that future patient-consumers and providers demand while still meeting current needs. That means moving away from current business models that depend on selling products and moving toward models that prioritize medtech’s role as trusted partner in a dynamic, connected health care ecosystem. Pamela Spence, EY Global Health Sciences and Wellness Industry Leader and Life Sciences Industry Leader, explains.